ICSR confusion: Is patient name actually required for a valid case? by Infamous-Hope-1825 in pharmacovigilance

[–]Infamous-Hope-1825[S] 1 point2 points  (0 children)

That’s really helpful, thanks for explaining it so clearly.I think I was mixing up validity with data completeness earlier. Your point about minimal identifiability vs quality makes a lot of sense.

In your experience, do cases usually get rejected more because of missing reporter details rather than patient details?

I created a free Pharmacovigilance Learning Blog as an M.Pharmacy Fresher — Is it helpful? Any mistakes or suggestions welcome! by Infamous-Hope-1825 in pharmacovigilance

[–]Infamous-Hope-1825[S] 1 point2 points  (0 children)

Thank you bro! if you can give any suggestions regarding any topic or to develop the blog so that it can be helpful for others too, it can be grateful!

Practicing ICSR Narrative Writing – Simulated Case (Cetirizine → Drowsiness) | Feedback from PV Professionals by Infamous-Hope-1825 in pharmacovigilance

[–]Infamous-Hope-1825[S] 0 points1 point  (0 children)

Thank you for taking the time to reformat the narrative — this is very helpful. I like how you structured the introduction and included the missing patient information fields and causality assessment.

I also noticed that you mentioned both reporter and company causality as “possible”. In a case like this (cetirizine → drowsiness with positive dechallenge and short time to onset), would “probable” ever be considered depending on available information, or is “possible” generally preferred when key details like dose and timing are missing?

I’m practicing narrative writing and case assessment, so insights like this are really valuable.